The traditional HR Business Partner (HRBP) model, once the gold standard for HR delivery, is undergoing a significant transformation. Many organizations, particularly in industries like pharmaceuticals, are moving towards a more agile resource model, aiming to streamline HR operations and…
HOME > REGULATORY
REGULATORY
- MHLW to Set Rules on OTC Switching of Diagnostics This Year
March 20, 2014
- MHLW to Draft Rules for Approval of Switch OTC Diagnostics in Meetings Open to the Public: Regulatory Reform Council
March 19, 2014
- MHLW OKs Additional Indications for Votrient, 2 Other Drugs
March 18, 2014
- FY2014 Reform to Strengthen Restrictions on Prescription of Multiple Psychotropic Drugs; Measures to Be Taken in Two Consecutive Reforms Due to Lack of Improvements
March 18, 2014
- PMDA to Up Review Fees for Generics, OTCs, Diagnostics in November
March 17, 2014
- Rules for Approval of Switch OTC Diagnostics to Be Finalized by PAFSC Committee by End of Year: PFSB Director General
March 17, 2014
- Eligibility for Key Pricing Premium Up for Discussion: Govt
March 17, 2014
- Opposition Lawmaker Raps Favorable Treatment for Special Zones in Mixed Healthcare
March 14, 2014
- Chuikyo Approves Promotion of Mixed Healthcare in National Strategic Special Zones, Reduction of Review Period by Half
March 14, 2014
- Committee for Assessment of Advanced Healthcare Services Holds 1st Meeting to Expedite Off-label Use of Anticancer Drugs under Senshin-iryo B program
March 13, 2014
- MHLW Notifies Prefectures of Rules on Online OTC Drug Sales
March 12, 2014
- Settlements Allowing Retroactive Modifications of Transaction Price Not Regarded as Settlements under New Price Cut Rule
March 12, 2014
- HPB’s Economic Affairs Division to Set Up Study Group to Monitor Progress of Roadmap to Promote Generic Drug Use
March 12, 2014
- Revisions of Prefectural Disaster Plans for Drug Distribution Almost Complete
March 11, 2014
- PAFSC’s Committee on Blood Programs Approves Standard Prices of Raw Plasma to Rise in FY2014 Due to Hike in Consumption Tax
March 11, 2014
- PMDA Raises Caution on Teratogenicity of Keratosis Treatment Tigason, Urges Use Only in Serious Cases
March 11, 2014
- Kitasato Daiichi Cannot Secure Flu Vaccine Production Capacity for 20 Million People by State Project Deadline
March 10, 2014
- Opposition Lawmaker Throws Doubts on Key Premium Given to Dellegra
March 7, 2014
- MHLW to Issue Notification Asking Doctors to Refrain from Selecting “No Substitution” Checkbox When Writing Prescriptions
March 7, 2014
- Basic Fees Paid to Pharmacies and Hospitals with Low Price Settlement Rates to Be Reduced under the New Rule from January 2015
March 7, 2014
ページ
Japan relies almost entirely on China for the APIs of β-lactam antibiotics. These drugs are essential for treating infectious diseases…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s key reimbursement policy panel on December 25 approved an outline of the FY2025 drug price revision, finalizing plans to…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
A Japanese health ministry panel discussing the generic industry structure on May 22 put together a report in which it…
The Ministry of Health, Labor and Welfare (MHLW) posted the final report compiled by its pharmaceutical regulation panel on its website on April 24, providing cases of drugs that could be exempted from all-case post marketing surveillance (PMS).The MHLW plans…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…
The Japanese health ministry’s expert panel tasked to discuss comprehensive policies for the rapid and stable supply of pharmaceuticals generally…